This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1jro
From Proteopedia
(New page: 200px<br /><applet load="1jro" size="450" color="white" frame="true" align="right" spinBox="true" caption="1jro, resolution 2.70Å" /> '''Crystal Structure of...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1jro.gif|left|200px]]<br /><applet load="1jro" size=" | + | [[Image:1jro.gif|left|200px]]<br /><applet load="1jro" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1jro, resolution 2.70Å" /> | caption="1jro, resolution 2.70Å" /> | ||
'''Crystal Structure of Xanthine Dehydrogenase from Rhodobacter capsulatus'''<br /> | '''Crystal Structure of Xanthine Dehydrogenase from Rhodobacter capsulatus'''<br /> | ||
==Overview== | ==Overview== | ||
| - | Xanthine dehydrogenase (XDH), a complex molybdo/iron-sulfur/flavoprotein, catalyzes the oxidation of hypoxanthine to xanthine followed by oxidation | + | Xanthine dehydrogenase (XDH), a complex molybdo/iron-sulfur/flavoprotein, catalyzes the oxidation of hypoxanthine to xanthine followed by oxidation of xanthine to uric acid with concomitant reduction of NAD+. The 2.7 A resolution structure of Rhodobacter capsulatus XDH reveals that the bacterial and bovine XDH have highly similar folds despite differences in subunit composition. The NAD+ binding pocket of the bacterial XDH resembles that of the dehydrogenase form of the bovine enzyme rather than that of the oxidase form, which reduces O(2) instead of NAD+. The drug allopurinol is used to treat XDH-catalyzed uric acid build-up occurring in gout or during cancer chemotherapy. As a hypoxanthine analog, it is oxidized to alloxanthine, which cannot be further oxidized but acts as a tight binding inhibitor of XDH. The 3.0 A resolution structure of the XDH-alloxanthine complex shows direct coordination of alloxanthine to the molybdenum via a nitrogen atom. These results provide a starting point for the rational design of new XDH inhibitors. |
==About this Structure== | ==About this Structure== | ||
| - | 1JRO is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Rhodobacter_capsulatus Rhodobacter capsulatus] with CA, FES, MPN, MOS and FAD as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Xanthine_dehydrogenase Xanthine dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.17.1.4 1.17.1.4] Full crystallographic information is available from [http:// | + | 1JRO is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Rhodobacter_capsulatus Rhodobacter capsulatus] with <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=FES:'>FES</scene>, <scene name='pdbligand=MPN:'>MPN</scene>, <scene name='pdbligand=MOS:'>MOS</scene> and <scene name='pdbligand=FAD:'>FAD</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Xanthine_dehydrogenase Xanthine dehydrogenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.17.1.4 1.17.1.4] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1JRO OCA]. |
==Reference== | ==Reference== | ||
| Line 16: | Line 16: | ||
[[Category: Kisker, C.]] | [[Category: Kisker, C.]] | ||
[[Category: Leimkuhler, S.]] | [[Category: Leimkuhler, S.]] | ||
| - | [[Category: Rajagopalan, K | + | [[Category: Rajagopalan, K V.]] |
[[Category: Rappa, R.]] | [[Category: Rappa, R.]] | ||
[[Category: Theis, K.]] | [[Category: Theis, K.]] | ||
| - | [[Category: Truglio, J | + | [[Category: Truglio, J J.]] |
[[Category: CA]] | [[Category: CA]] | ||
[[Category: FAD]] | [[Category: FAD]] | ||
| Line 27: | Line 27: | ||
[[Category: partial beta-barrel; xdh; xo]] | [[Category: partial beta-barrel; xdh; xo]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:26:00 2008'' |
Revision as of 11:26, 21 February 2008
|
Crystal Structure of Xanthine Dehydrogenase from Rhodobacter capsulatus
Overview
Xanthine dehydrogenase (XDH), a complex molybdo/iron-sulfur/flavoprotein, catalyzes the oxidation of hypoxanthine to xanthine followed by oxidation of xanthine to uric acid with concomitant reduction of NAD+. The 2.7 A resolution structure of Rhodobacter capsulatus XDH reveals that the bacterial and bovine XDH have highly similar folds despite differences in subunit composition. The NAD+ binding pocket of the bacterial XDH resembles that of the dehydrogenase form of the bovine enzyme rather than that of the oxidase form, which reduces O(2) instead of NAD+. The drug allopurinol is used to treat XDH-catalyzed uric acid build-up occurring in gout or during cancer chemotherapy. As a hypoxanthine analog, it is oxidized to alloxanthine, which cannot be further oxidized but acts as a tight binding inhibitor of XDH. The 3.0 A resolution structure of the XDH-alloxanthine complex shows direct coordination of alloxanthine to the molybdenum via a nitrogen atom. These results provide a starting point for the rational design of new XDH inhibitors.
About this Structure
1JRO is a Protein complex structure of sequences from Rhodobacter capsulatus with , , , and as ligands. Active as Xanthine dehydrogenase, with EC number 1.17.1.4 Full crystallographic information is available from OCA.
Reference
Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus., Truglio JJ, Theis K, Leimkuhler S, Rappa R, Rajagopalan KV, Kisker C, Structure. 2002 Jan;10(1):115-25. PMID:11796116
Page seeded by OCA on Thu Feb 21 13:26:00 2008
